drugset / Trial / NCT01935570
Comparative Study of the Bioavailability of Magnesium Administrated by Two ChronoMag Smart Tablet® 50 mg Versus Three Mag2® Tablets 100mg.
Phase 1
Completed
17 enrolled
University Hospital, Clermont-Ferrand
Dr Gilles DUCHEIX (Attaché)(Clinical Pharmacology center, Inserm 501) · collabDr Gisèle PICKERING (MCU-PH)(Clinical Pharmacology center, Inserm 501) · collab
RandomizedCrossoverDouble-blindTreatment
Summary
This clinical study is composed of two steps. The first step aims at validating the pharmacokinetic approach based on the magnesium concentration in erythrocyte and plasma. According to these results and if this pharmacokinetic approach is validated, the second step will set up. The second phase aims at comparing the relative bioavailability of magnesium administrated by two different drug formulations: ChronoMag Smart Tablet® (two tablets50mg) versus Mag2® (three tablets100mg).
Timeline
- Start
- 2013-09
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MAGNESIUM CHLORIDE ANHYDROUS | Small molecule | 50 mg | — |
| Subject | Magnesium carbonate | Small molecule | 100 mg | — |
Indications
No indication recorded.